Rubicon Organics (ROMJ) Aktienübersicht
Rubicon Organics Inc. ist zusammen mit seinen Tochtergesellschaften in der Produktion, der Verarbeitung und dem Verkauf von organischem Cannabis für den Freizeit- und medizinischen Markt in Kanada und international tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 3/6 |
| Dividenden | 0/6 |
ROMJ Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Rubicon Organics Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | CA$0.47 |
| 52-Wochen-Hoch | CA$0.73 |
| 52-Wochen-Tief | CA$0.37 |
| Beta | 0.38 |
| 1 Monat Veränderung | 4.44% |
| 3 Monate Veränderung | 9.30% |
| 1 Jahr Veränderung | -9.62% |
| 3 Jahre Veränderung | 2.17% |
| 5 Jahre Veränderung | -79.39% |
| Veränderung seit IPO | -85.54% |
Aktuelle Nachrichten und Updates
Recent updates
ROMJ: Cascadia Harvest Ramp Will Support Future Premium Capacity Upside
Analysts kept their fair value estimate for Rubicon Organics steady at CA$1.15, citing unchanged views on the discount rate, revenue growth expectations, profit margin assumptions and long term P/E outlook. What's in the News Rubicon Organics completed the first harvest of cannabis from its new Cascadia facility in Hope, British Columbia, following its acquisition in June 2025 (Key Developments).ROMJ: Cascadia Facility Ramp Up Will Support Future Premium Capacity Expansion
Analysts have kept their CA$1.15 price target on Rubicon Organics unchanged, citing essentially flat fair value, discount rate, revenue growth, profit margin, and a very high future P/E estimate that remains in place even after the latest refresh of their assumptions. What's in the News Rubicon Organics completed the first harvest of cannabis at its new Cascadia facility in Hope, British Columbia, after acquiring the site in June 2025 and preparing it for commercial production through capital investment and licensing work (Key Developments).ROMJ: New Permanent CFO Will Support Future Premium Capacity Expansion
Analysts have maintained their fair value estimate for Rubicon Organics at CA$1.15, indicating only very small adjustments to the discount rate, margin, and long-term P/E assumptions rather than any material change in their overall view. What's in the News Rubicon Organics appointed Glen Ibbott as Chief Financial Officer, formalizing his role after serving as interim CFO for about six months (Key Developments).ROMJ: New Permanent CFO Will Support Premium Capacity Expansion
The analyst price target for Rubicon Organics is unchanged at $1.15, as analysts see only minimal tweaks to inputs such as discount rate, revenue growth and profit margin that do not meaningfully alter their overall view of the shares. What's in the News Rubicon Organics appointed Glen Ibbott as Chief Financial Officer, following a six month period in which he served as interim CFO (Key Developments).ROMJ: New CFO And Cascadia License Will Support Premium Capacity Expansion
Analysts maintained their price target for Rubicon Organics at $1.15, citing only minor adjustments in their underlying assumptions for discount rate, revenue growth, profit margin and future P/E as the reason for no material change in their valuation view. What's in the News Rubicon Organics appointed Glen Ibbott, a veteran cannabis and life sciences finance executive and former CFO of Aurora Cannabis, as its Chief Financial Officer after serving as interim CFO for six months (Key Developments).ROMJ: New Licensed Facility Will Drive Premium Capacity Expansion By 2026
Analysts have maintained their price target on Rubicon Organics at approximately $1.15 per share, reflecting largely unchanged assumptions for revenue growth, profitability, and valuation multiples in their updated models. What's in the News Rubicon Organics appointed industry veteran Glen Ibbott, former CFO of Aurora Cannabis, as its new Chief Financial Officer after serving six months in an interim role, bringing over 25 years of public-company finance and cannabis sector experience (Key Developments).ROMJ: New Facility Expansion Will Support Premium Cannabis Output Growth By 2026
Analysts have maintained their price target for Rubicon Organics at 1.15 dollars, reflecting largely unchanged assumptions for growth, profitability, and valuation multiples in their updated models. What's in the News Rubicon Organics appointed Glen Ibbott, former Aurora Cannabis CFO with over 25 years of life sciences and cannabis finance leadership, as its new Chief Financial Officer after serving six months in an interim capacity (Key Developments).ROMJ: Cascadia Facility Expansion Will Increase Output by 40% by 2026
Analysts have reaffirmed Rubicon Organics' fair value estimate at $1.15, citing increased revenue growth projections that are balanced by a significant reduction in profit margin expectations. This combination has resulted in minimal change to the overall price target.ROMJ: Cascadia Facility Expansion Will Drive 40% Output Increase By 2026
Analysts maintained their price target for Rubicon Organics at $1.15. This reflects stable expectations, despite minor adjustments to sector discount rates and growth assumptions.We Think Rubicon Organics (CVE:ROMJ) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Facility Will Drive 40% Capacity Increase And Long-Term Upside
Narrative Update on Rubicon Organics Analysts have maintained their fair value price target for Rubicon Organics at $1.15. Recent reassessments indicate minimal changes to underlying growth and profitability assumptions.Global Cannabis Acceptance And Facility Expansion Will Unlock Long-Term Opportunity
Analysts have revised their price target for Rubicon Organics downward by $0.15 to $1.15 per share, citing tempered revenue growth expectations. This adjustment comes despite a modest improvement in projected profit margins and a lower future price-to-earnings ratio.International Certifications And Capacity Expansion Will Unlock Premium Cannabis Markets
Driven by notable improvements in both forecasted revenue growth (from 10.6% to 16.3% annually) and net profit margin (from 2.67% to 4.92%), Rubicon Organics' consensus analyst price target has been raised from CA$1.10 to CA$1.30. What's in the News Rubicon Organics launched its new 1964 Supply Co. All-in-One Full Spectrum Extract Resin Vapes in Canada, featuring premium resin and targeting legacy market consumers; two more AIO products are planned by year-end.Rubicon Organics Inc.'s (CVE:ROMJ) Price Is Out Of Tune With Revenues
TSXV:ROMJ 1 Year Share Price vs Fair Value Explore Rubicon Organics's Fair Values from the Community and select yours...International Certifications And Capacity Expansion Will Unlock Premium Cannabis Markets
Certifications, facility expansion, and new exports position Rubicon Organics for broader international growth, revenue diversification, and increased premium product supply.Investors Still Aren't Entirely Convinced By Rubicon Organics Inc.'s (CVE:ROMJ) Revenues Despite 37% Price Jump
Rubicon Organics Inc. ( CVE:ROMJ ) shareholders would be excited to see that the share price has had a great month...Is Rubicon Organics (CVE:ROMJ) Using Debt Sensibly?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Slammed 30% Rubicon Organics Inc. (CVE:ROMJ) Screens Well Here But There Might Be A Catch
Rubicon Organics Inc. ( CVE:ROMJ ) shareholders won't be pleased to see that the share price has had a very rough...A Piece Of The Puzzle Missing From Rubicon Organics Inc.'s (CVE:ROMJ) 26% Share Price Climb
Rubicon Organics Inc. ( CVE:ROMJ ) shareholders would be excited to see that the share price has had a great month...Health Check: How Prudently Does Rubicon Organics (CVE:ROMJ) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Rubicon Organics Inc. (CVE:ROMJ) Soars 27% But It's A Story Of Risk Vs Reward
Rubicon Organics Inc. ( CVE:ROMJ ) shares have had a really impressive month, gaining 27% after a shaky period...Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)
Key Insights Rubicon Organics' estimated fair value is CA$0.32 based on 2 Stage Free Cash Flow to Equity Current share...Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet
To the annoyance of some shareholders, Rubicon Organics Inc. ( CVE:ROMJ ) shares are down a considerable 26% in the...Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Aktionärsrenditen
| ROMJ | CA Pharmaceuticals | CA Markt | |
|---|---|---|---|
| 7D | -4.1% | -0.5% | 0.7% |
| 1Y | -9.6% | -8.1% | 31.0% |
Rendite im Vergleich zur Industrie: ROMJ unter dem Niveau der Branche Canadian Pharmaceuticals , die im vergangenen Jahr eine Rendite von -8.1% erzielte.
Rendite vs. Markt: ROMJ hinter dem Markt Canadian zurück, der im vergangenen Jahr eine Rendite von 31 erzielte.
Preisvolatilität
| ROMJ volatility | |
|---|---|
| ROMJ Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 8.9% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in CA Market | 16.5% |
| 10% least volatile stocks in CA Market | 3.8% |
Stabiler Aktienkurs: ROMJ hatte in den letzten 3 Monaten im Vergleich zum Canadian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: ROMJDie wöchentliche Volatilität (9%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2015 | 265 | Margaret Brodie | www.rubiconorganics.com |
Rubicon Organics Inc. und seine Tochtergesellschaften beschäftigen sich mit der Produktion, der Verarbeitung und dem Verkauf von organischem Cannabis für den Freizeit- und medizinischen Gebrauch in Kanada und international. Das Unternehmen bietet Cannabisprodukte in Form von Gläsern, Beuteln, Pre-Rolls, essbaren Produkten, Poutine-Saucenmischungen, gemahlenen Blüten, Softgels, Haschisch, Blunt, Gummibärchen, Blütenmischungen, Pot Brownies, Resin Vape, Relief Stick, Cool Stick und Öl an. Es vertreibt seine Produkte unter den Markennamen Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, LAB THEORY und Wildflower.
Rubicon Organics Inc.'s Grundlagenzusammenfassung
| ROMJ grundlegende Statistiken | |
|---|---|
| Marktanteil | CA$29.73m |
| Gewinn(TTM) | -CA$1.74m |
| Umsatz(TTM) | CA$64.23m |
Ist ROMJ zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| ROMJ Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | CA$64.23m |
| Kosten der Einnahmen | CA$41.11m |
| Bruttogewinn | CA$23.12m |
| Sonstige Ausgaben | CA$24.86m |
| Gewinn | -CA$1.74m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -0.026 |
| Bruttomarge | 35.99% |
| Nettogewinnspanne | -2.71% |
| Schulden/Eigenkapital-Verhältnis | 33.3% |
Wie hat sich ROMJ auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/17 19:13 |
| Aktienkurs zum Tagesende | 2026/08/17 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Rubicon Organics Inc. wird von 7 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Nicholas Cortellucci | Atrium Research |
| Ben Pirie | Atrium Research |
| Kimberly Thompson-Hedlin | Canaccord Genuity |